Kyle Moran, CFA, is the Chief Financial Officer at WAVE LIFE SCIENCES LTD, a biotechnology company focused on developing innovative treatments for genetic diseases. With over two decades of experience in financial management and strategic planning, Moran has become a vital asset to the company. Before joining WAVE LIFE SCIENCES LTD, he held several high-level positions at various organizations, including CFO at Orchard Therapeutics, where he played a crucial role in the company's successful IPO and subsequent growth. Moran's strong background in finance, coupled with his expertise in the life sciences industry, has enabled him to effectively guide WAVE LIFE SCIENCES LTD through the complex financial landscape of biotechnology. As CFO, Moran is responsible for overseeing the company's financial operations, including budgeting, forecasting, and financial reporting. He works closely with the executive team to develop and implement strategic initiatives that drive the company's growth and profitability. Under his leadership, WAVE LIFE SCIENCES LTD has made significant strides in advancing its pipeline of novel therapies, securing partnerships with leading pharmaceutical companies, and attracting investment from top-tier investors. Moran's ability to navigate the challenges of the biotechnology industry has been instrumental in positioning WAVE LIFE SCIENCES LTD as a leader in the field of genetic medicine. In addition to his professional achievements, Moran is a Chartered Financial Analyst (CFA) charterholder, a designation that reflects his commitment to the highest standards of ethical and professional conduct in the investment industry. He holds an MBA from the University of Chicago Booth School of Business and a Bachelor of Science in Finance from the University of Illinois at Urbana-Champaign. Moran's expertise, leadership, and dedication to advancing the mission of WAVE LIFE SCIENCES LTD make him an invaluable member of the team as the company continues to push the boundaries of genetic medicine.